Search results for " must"

showing 10 items of 65 documents

PARTIAL SEQUENCING OF THE BETA-GLUCOSIDASE-ENCODING GENE FROM YEAST STRAINS ISOLATED FROM MUSTS AND WINES

2008

The aim of the present work was the identification of the gene encoding for β-glucosidase and its partial sequencing in the strainsPichia anomala AL112,Hanseniaspora uvarum Y8 andSaccharomyces cerevisiae AL41. To this aim degenerated primers, designed on the basis of aminoacid similarities of four known yeast β-glucosidases, have been used in PCR amplifications. An expected fragment of about 200 bp was amplified from all the DNAs, cloned and sequenced. Sequence homology demonstrated for the first time the presence of a β-glucosidase encoding gene inHanseniaspora uvarum andSaccharomyces cerevisiae.

GeneticsBETA-GLUCOSIDASEbiologyPichia anomalaAscomycotaGENE PARTIAL SEQUENCINGSaccharomyces cerevisiaeSICILIAN MUSTSbiology.organism_classificationHanseniasporaSettore BIO/19 - Microbiologia GeneraleApplied Microbiology and BiotechnologyYeastGENE PARTIAL SEQUENCING; BETA-GLUCOSIDASE; SICILIAN MUSTSDNA glycosylaseβ-glucosidase gene partial sequencing Hanseniaspora uvarum Pichia anomala Saccharomyces cerevisiaeGenePichia
researchProduct

The yeast Starmerella bacillaris (synonym Candida zemplinina) shows high genetic diversity in winemaking environments.

2015

International audience; The yeast Candida zemplinina (Starmerella bacillaris) is frequently isolated from grape and wine environments. Its enological use in mixed fermentation with Saccharomyces cerevisiae has been extensively investigated these last few years, and several interesting features including low ethanol production, fructophily, glycerol and other metabolites production, have been described. In addition, molecular tools allowing the characterization of yeast populations have been developed, both at the inter- and intraspecific levels. However, most of these fingerprinting methods are not compatible with population genetics or ecological studies. In this work, we developed 10 micr…

GlycerolStarmerella bacillaris microsatellite SSR oenology grape mustmicrosatelliteGenotypeGenotyping Techniques[SDV]Life Sciences [q-bio]Saccharomyces cerevisiaePopulation geneticsWineFructoseSaccharomyces cerevisiaestarmerella bacillarisApplied Microbiology and BiotechnologyMicrobiology[SDV.IDA]Life Sciences [q-bio]/Food engineeringBotanymust[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringVitisSelection GeneticDNA FungalWinemakingOenologyCandidaWineGenetic diversitybiologyBase SequenceEthanolGeographyGenetic VariationGeneral MedicineSequence Analysis DNAgrapebiology.organism_classificationSSRYeastCandida zemplininaFermentationoenologyGenome FungalMicrosatellite Repeats
researchProduct

The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanoma.

1995

The role of interleukin-2 (IL-2) on tumor growth of B16F10 melanoma cells was assessed in two sets of mice with different immune status: normal (immunocompetent) mice and immunodeficient mice. The two sets of animals were treated with cyclophosphamide (CY) or IL-2 alone or with a combined therapy of CY+IL-2. On days 6 and 10 after tumor cell injection, we evaluated the incidence of hepatic B16 melanoma metastases and the percentage of hepatic volume occupied by metastatic tissue. We observed that the CY alone (300 mg/kg, days 3 and 8 post-tumoral inoculation) significantly reduced tumor growth in all treated mice; however, CY proved more effective in normal recipients than in immunodeficien…

Interleukin 2Cancer ResearchPathologymedicine.medical_specialtyCyclophosphamideRatónmedicine.medical_treatmentImmunologyMelanoma ExperimentalInjectionsAndrologychemistry.chemical_compoundImmunocompromised HostMiceIn vivomedicineImmunology and AllergyAnimalsImmunologic FactorsDrug InteractionsCyclophosphamideChemotherapybusiness.industryLiver NeoplasmsReceptors Interleukin-2Combined Modality TherapyNitrogen mustardNeoplasm ProteinsMice Inbred C57BLCytokineOncologychemistryToxicityInterleukin-2FemalebusinessImmunocompetenceNeoplasm TransplantationSpleenWhole-Body Irradiationmedicine.drugCancer immunology, immunotherapy : CII
researchProduct

Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma

2015

In this phase I/II study, we explored the combination of Temsirolimus with Bendamustine and Rituximab (BeRT) in patients with r/r follicular lymphoma (FL) or mantle cell lymphoma (MCL). Patients with 1-3 prior therapies received Bendamustine (90 mg/m(2), day 1+2) and Rituximab (375 mg/m(2), day 1) with Temsirolimus in doses from 25 to 75 mg added on day 1, 8, 15 of a 28-day cycle. Fifteen (11 MCL, 4 FL) patients were included in the phase I. Median age was 73 years and median pretreatment number was 2. No formal dose-limiting toxicity was observed. Dominant non-hematological side effects were fatigue in 11 (73%), nausea in 9 (60%), mucositis in 7 (47%) and vomiting in 6 patients (40%). Coug…

MaleBendamustineCancer Researchmedicine.medical_specialtyMaximum Tolerated DoseFollicular lymphomaLymphoma Mantle-CellNeutropeniaGastroenterologyAntibodies Monoclonal Murine-Derivedhemic and lymphatic diseasesInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineMucositisBendamustine HydrochlorideHumansProspective StudiesLymphoma FollicularAgedNeoplasm StagingSirolimusLeukopeniabusiness.industryRemission InductionHematologyMiddle AgedPrognosismedicine.diseaseTemsirolimusSurgerySurvival RateOncologyNitrogen Mustard CompoundsFeasibility StudiesFemaleMantle cell lymphomaRituximabNeoplasm Recurrence LocalSafetymedicine.symptomRituximabbusinessFollow-Up Studiesmedicine.drugLeukemia
researchProduct

Affinity and efficacy of racemic, (+)-, and (−)-methacholine in muscarinic inhibition of [3H]-noradrenaline release

1985

The right postganglionic sympathetic nerves of rat isolated perfused hearts (previously loaded with [3H]-noradrenaline) were stimulated electrically with 10 trains of 10 pulses at 10 Hz. The inhibition by methacholine of stimulation-evoked [3H]-noradrenaline overflow into the perfusate (determined in the presence of corticosterone, desipramine, phentolamine, and propranolol) was taken as a measure for activation of presynaptic muscarinic receptors. The evoked [3H]-noradrenaline overflow was inhibited by (+)-, racemic, and (-)-methacholine in a reversible and concentration-dependent manner. The concentration causing 50% inhibition (IC50) was 0.1, 0.26, and 65 microM, respectively, resulting …

MaleReceptor complexSympathetic Nervous SystemIntrinsic activityPhenoxybenzamineStereochemistryPhysostigminePropranololIn Vitro TechniquesPropylbenzilylcholine MustardNorepinephrineMuscarinic acetylcholine receptormedicineAnimalsMethacholine CompoundsDrug InteractionsReceptorMethacholine ChlorideNeuronsPharmacologyPhenoxybenzamineChemistryHeartRats Inbred StrainsStereoisomerismReceptors MuscarinicElectric StimulationRatsDissociation constantSynapsesMethacholineCorticosteroneResearch Articlemedicine.drugBritish Journal of Pharmacology
researchProduct

Ontogenetic trophic segregation between two threatened smooth-hound sharks in the Central Mediterranean Sea

2020

AbstractElasmobranchs are among the species most threatened by overfishing and a large body of evidence reports their decline around the world. As they are large predators occupying the highest levels of marine food webs, their removal can alter the trophic web dynamic through predatory release effects and trophic cascade. Suitable management of threatened shark species requires a good understanding of their behaviour and feeding ecology. In this study we provide one of the first assessments of the trophic ecology of the “vulnerable” smooth-hounds Mustelus mustelus and M. punctulatus in the Central Mediterranean Sea, based on stomach contents and stable isotope analyses. Ontogenetic diet ch…

MaleSettore BIO/07 - Ecologia0106 biological sciencesConservation of Natural ResourcesStable isotope analysisBehavioural ecologyPalinurus elephaslcsh:MedicineMustelus mustelusZoology010603 evolutionary biology01 natural sciencesArticlemesopredatorsPredationMustelus punctulatusMediterranean Seastable isotopeAnimalslcsh:ScienceTrophic cascaderesource partitioningTrophic levelMultidisciplinarybiology010604 marine biology & hydrobiologylcsh:RInterspecific competitiongut contentsbiology.organism_classificationAnimal FeedFood webtrophic nicheIsotope LabelingThreatened speciesSharksMustelus musteluslcsh:QFemale
researchProduct

Synthesis and analysis of activity of a potential anti-melanoma prodrug with a hydrazine linker

2013

A potential anti-melanoma prodrug containing a phenolic activator, a hydrazine linker, and a nitrogen mustard effector - (N-{4-[bis-(2-chloroethyl)amino]benzoyl}-N'-(4-hydroxybenzyl)hydrazine) has been synthesized in seven steps. Spectrophotometric measurements of its oxidation by tyrosinase showed a rapid increase of absorbance at 337 nm. HPLC analysis demonstrated that two major products were formed. However, during the reaction one of the products was converted into the other. The stable product with a maximum of absorption at 337 nm was isolated and identified as 5,6-dihydroxy-1H-indazol-1-yl 4-[bis-(2-chloroethyl)amino]benzoate. It was formed by a cyclization of the enzymatically gener…

MelphalanStereochemistryTyrosinaseHydrazineMelanoma Experimentaltyrosinasechemistry.chemical_compoundMiceNucleophileCell Line TumorDrug DiscoverymedicineAnimalsProdrugsMechlorethamineTyrosineneoplasmsPharmacologyanti-melanoma prodrugChemistryMonophenol MonooxygenaseOrganic Chemistrynitrogen mustardhydrazineGeneral MedicineProdrugNitrogen mustardHydrazinesCyclizationLinkermedicine.drugEuropean Journal of Medicinal Chemistry
researchProduct

The Potential of the Yeast Debaryomyces hansenii H525 to Degrade Biogenic Amines in Food

2015

Twenty-six yeasts from different genera were investigated for their ability to metabolize biogenic amines. About half of the yeast strains produced one or more different biogenic amines, but some strains of Debaryomyces hansenii and Yarrowia lipolytica were also able to degrade such compounds. The most effective strain D. hanseniii H525 metabolized a broad spectrum of biogenic amines by growing and resting cells. Degradation of biogenic amines by this yeast isolate could be attributed to a peroxisomal amine oxidase activity. Strain H525 may be useful as a starter culture to reduce biogenic amines in fermented food.

Microbiology (medical)Yarrowia lipolytica copper amine oxidasebiologyStrain (chemistry)Effective strainbiogenic aminesYarrowiaPeroxisomebiology.organism_classificationMicrobiologyArticleYeastcheeselcsh:Biology (General)Biochemistryyeasts Debaryomyces hanseniiVirologyDebaryomyces hanseniiyeasts <i>Debaryomyces hanseniigrape mustYarrowia lipolytica</i> copper amine oxidaselcsh:QH301-705.5Fermentation in food processingAmine oxidase activityMicroorganisms
researchProduct

Pyrrolo[2,1-d][1,2,3,5]tetrazine-4(3H)-ones, a new class of azolotetrazines with potent antitumor activity.

2003

Pyrrolo[2,1-d][1,2,3,5]tetrazinones 10a-o, compounds that hold the deaza skeleton of the antitumor drug temozolomide, were prepared by reaction of 2-diazopyrroles 9 and isocyanates. Such a synthetic route represents, among those leading to azolotetrazinones reported so far, the only possible one since attempts to cyclize to the title ring system 2-amino-1-carbamoylpyrroles 11 or the mono substituted 2-triazenopyrrole 12 failed. Compounds 10 were screened at the National Cancer Institute (NCI) for their activity against a panel of about 60 human tumor cell lines. Most of them possess remarkable antineoplastic activity having GI(50) values in the low micromolar or sub-micromolar range and rea…

NitrileStereochemistryHL60Clinical BiochemistryPharmaceutical ScienceAntineoplastic AgentsHL-60 CellsBiochemistryChemical synthesischemistry.chemical_compoundTetrazineMiceStructure-Activity RelationshipDrug DiscoverymedicineStructure–activity relationshipAnimalsHumansPyrrolesMolecular BiologyTemozolomideBicyclic moleculeOrganic ChemistryImidazolesMechanism of actionchemistryNitrogen Mustard CompoundsMolecular Medicinemedicine.symptomDrug Screening Assays AntitumorK562 Cellsmedicine.drugIsocyanatesBioorganicmedicinal chemistry
researchProduct

Antiblastic Drug Combinations with Ifosfamide: An Update

2003

Ifosfamide is an alkylating agent that is widely used in the treatment of various neoplasms, such as sarcomas, lymphomas, pediatric malignancies, germ cell tumors, lung, breast and ovarian cancer. The clinical toxicity of ifosfamide depends on the dose and administration schedules. The pharmacologic features of this drug enable its combination with other antiblastic agents, such as vinorelbine, gemcitabine, paclitaxel and docetaxel. Moreover, the pharmacologic profile of ifosfamide allows the use of this antiblastic drug in patients who have previously failed many other treatments, and a large percentage of responses has already been obtained. There is some concern about the optimal schedul…

OncologyDrugCancer Researchmedicine.medical_specialtyPaclitaxelmedia_common.quotation_subjectDocetaxelPharmacologyVinblastineVinorelbineDeoxycytidineDrug Administration Schedulechemistry.chemical_compoundInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineAnimalsHumansIfosfamideAntineoplastic Agents Alkylatingmedia_commonIfosfamidebusiness.industryVinorelbineGeneral MedicineGemcitabineNitrogen mustardGemcitabineClinical trialOncologyDocetaxelPaclitaxelchemistryCamptothecinTaxoidsbusinessmedicine.drugOncology
researchProduct